A Comprehensive Method for Assessing the Blepharospasm Cases Severity

about

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

Item

http://www.wikidata.org/entity/Q58225346

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2017

@uk

name

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

@en

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

@nl

type

Item

label

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

@en

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

@nl

prefLabel

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

@en

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

@nl

P1476

A Comprehensive Method for Assessing the Blepharospasm Cases Severity

@en

P2093

Antonio Emmanuele Uva

http://www.w3.org/2001/XMLSchema#string

Attilio Nicola Nocera

http://www.w3.org/2001/XMLSchema#string

Enrico Nasca

http://www.w3.org/2001/XMLSchema#string

Giacomo Donato Cascarano

http://www.w3.org/2001/XMLSchema#string

Gianpaolo Francesco Trotta

http://www.w3.org/2001/XMLSchema#string

Giovanni Defazio

http://www.w3.org/2001/XMLSchema#string

Maurizio Dimatteo

http://www.w3.org/2001/XMLSchema#string

Michele Fiorentino

http://www.w3.org/2001/XMLSchema#string

Nicholas Caporusso

http://www.w3.org/2001/XMLSchema#string

Roberta Pellicciari

http://www.w3.org/2001/XMLSchema#string

P2860

Development and validation of a clinical scale for rating the severity of blepharospasm.

Blepharospasm: a review of 264 patients.

Update on blepharospasm: report from the BEBRF International Workshop

Do primary adult-onset focal dystonias share aetiological factors?

The focal dystonias: current views and challenges for future research

Difficulties with differentiating botulinum toxin treatment effects in essential blepharospasm.

Can methylphenidate objectively provide relief in patients with uncontrolled blepharospasm? A pilot study using surface electromyography.

Long-term assessment of the risk of spread in primary late-onset focal dystonia.

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.

Rating scales for dystonia: a multicenter assessment.

P304

369-381

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-981-10-4859-3_33

http://www.w3.org/2001/XMLSchema#string

P50

Vitoantonio Bevilacqua

Antonio Brunetti

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime